Why choose Acon laboratories?
ACON Laboratories makes Point-of-care medical diagnostics affordable to people all around the world. We provide rapid diagnostics and healthcare products based on a philosophy of high quality, affordability and superior flexibility. Our product lines include Point of Care, Immunoassays, Molecular Diagnostics and Animal Health.
What kind of products does Acon make?
Product Focus. ACON’s current product lines include Diabetes Care, Urinalysis, Immunoassays, Point of Care Testing, and Veterinary Diagnostics. These products are used in a variety of channels including hospitals, clinical laboratories, physician offices, blood banks, pharmacies and veterinary clinics and other channels in 130 countries.
What is aclarion technology?
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), and a proprietary biomarker to optimize clinical treatments. The first application of Aclarion’s technology addresses the $134.5B U.S. low back and neck pain market.
How much money does aclarion make a year?
In 2021, Aclarion's revenue was $60,292, an increase of 23.93% compared to the previous year's $48,652. Losses were -$4.95 million, 6.80% more than in 2020.
IS Acon Labs a publicly traded company?
ACON Laboratories Inc. is a privately owned Diagnostics and Medical Device company, which was founded in 1996, with its headquarters located in San Diego, California.
Who owns the most stock in Acon Laboratories?
Looking at our data, we can see that the largest shareholder is ACON Investments, L.L.C. with 20% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 6.4% and 3.8%, of the shares outstanding, respectively.
Who owns ACON Laboratories Inc?
Lin JixunLin Jixun is the Founder & CEO at ACON Laboratories . Additionally, Lin Jixun has had 1 past job as the Co-Founder at ACEA BIO .
Is ACON Laboratories a Chinese company?
The ACON name is well known in over 130 countries. Our state of the art manufacturing facility located in Hangzhou, China is ISO13485: 2016 certified, FDA registered, and has been inspected by US FDA.
How has Aclarion's stock performed in 2022?
Aclarion's stock was trading at $2.07 at the beginning of the year. Since then, ACON shares have decreased by 50.7% and is now trading at $1.02. V...
Who are Aclarion's key executives?
Aclarion's management team includes the following people: Dr. Jeffrey John Thramann M.D. , Exec. Chairman (Age 57, Pay $300k) Mr. Brent Ness ,...
Who are some of Aclarion's key competitors?
Some companies that are related to Aclarion include OpGen (OPGN) , Biocept (BIOC) , Vyant Bio (VYNT) , PharmChem (PCHM) , American Shared Hosp...
When did Aclarion IPO?
(ACON) raised $12 million in an IPO on Friday, April 22nd 2022. The company issued 2,165,000 shares at $4.50-$6.50 per share.
What is Aclarion's stock symbol?
Aclarion trades on the NASDAQ under the ticker symbol "ACON."
When did the company's quiet period expire?
Aclarion's quiet period expired on Wednesday, June 1st. Aclarion had issued 2,165,000 shares in its IPO on April 22nd. The total size of the offeri...
How do I buy shares of Aclarion?
Shares of ACON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Aclarion's stock price today?
One share of ACON stock can currently be purchased for approximately $1.02.
How much money does Aclarion make?
Aclarion (NASDAQ:ACON) has a market capitalization of $7.98 million.
Making Point-of-care testing affordable around the world
Better Clinical Outcomes
Our product lines include Point of Care, Immunoassays, Molecular Diagnostics and Animal Health.
